The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-15 of 15 articles
Clinical outcomes by optical characteristics of neointima and treatment modality in patients with coronary in-stent restenosis
Xhepa E,
Bresha J,
Joner M,
Hapfelmeier A,
Rivero F,
Ndrepepa G,
Nano N,
Cuesta J,
Kufner S,
Cassese S,
Bastante T,
Aytekin A,
Rroku A,
García-Guimaraes M,
Lahmann A,
Pinieck S,
Rai H,
Fusaro M,
Schunkert H,
Pérez-Vizcayno M,
Gonzalo N,
Alfonso F,
Kastrati A
August 6, 2021 | 10.4244/EIJ-D-20-00662
Obesity paradox after percutaneous coronary intervention - closing in on the truth behind the phenomenon
January 17, 2020 | 10.4244/EIJV15I13A208
No-reflow after percutaneous coronary intervention: a correlate of poor outcome in both persistent and transient forms
June 20, 2018 | 10.4244/EIJV14I2A21
Outcomes of patients treated with ultrathin-strut biodegradable polymer sirolimus-eluting stents versus fluoropolymer-based everolimus-eluting stents: a meta-analysis of randomised trials
Cassese S,
Ndrepepa G,
Byrne RA,
Kufner S,
Lahmann A,
Mankerious N,
Xhepa E,
Laugwitz K,
Schunkert H,
Fusaro M,
Kastrati A,
Joner M
June 20, 2018 | 10.4244/EIJ-D-18-00024
Midterm clinical outcomes with everolimus-eluting bioresorbable scaffolds versus everolimus-eluting metallic stents for percutaneous coronary interventions: a meta-analysis of randomised trials
Cassese S,
Byrne RA,
Jüni P,
Wykrzykowska JJ,
Puricel S,
Ndrepepa G,
Schunkert H,
Fusaro M,
Cook S,
Kimura T,
Henriques J,
Serruys P,
Windecker S,
Kastrati A
January 19, 2018 | 10.4244/EIJ-D-17-00492
Outcomes of patients treated with durable polymer platinum-chromium everolimus-eluting stents: a meta-analysis of randomised trials
Cassese S,
Ndrepepa G,
Byrne RA,
Kufner S,
Xhepa E,
De Waha A,
Rheude T,
Colleran R,
Giacoppo D,
Harada Y,
Laugwitz K,
Schunkert H,
Fusaro M,
Kastrati A
October 20, 2017 | 10.4244/EIJ-D-16-00871
Mechanical strategies to enhance myocardial salvage during primary percutaneous coronary intervention in patients with STEMI
June 20, 2016 | 10.4244/EIJV12I3A52
Impact of bivalirudin on post-procedural epicardial blood flow, risk of stent thrombosis and mortality after percutaneous coronary intervention
Fiedler A,
Ndrepepa G,
Schulz S,
Floh S,
Hoppmann P,
Kufner S,
Bernlochner I,
Byrne RA,
Schunkert H,
Laugwitz K,
Kastrati A
February 12, 2016 | 10.4244/EIJV11I11A249
Latest news
NEW ISSUE
The Bifurcation ARC consensus; impact of P2Y12 de-escalation in HBR; 5-year outcomes of the TARGET trial and more...
December 4, 2023
STATE-OF-THE-ART
Free access collection all year long
December 4, 2023
AHEAD OF PRINT
Poor improvement of post-PCI iFR in LAD
FREE ARTICLE - Mitsuaki Matsumura et al
November 30, 2023
AHEAD OF PRINT
Robotic-assisted CABG: clinical outcomes
FREE ARTICLE - Aleksander Dokollari et al
November 23, 2023
AHEAD OF PRINT
Pathophysiological CAD patterns predict outcomes post-PCI
FREE ARTICLE - Nozomi Kotoku et al
November 14, 2023
PCR London Valves 2023
November 16, 2023
AHEAD OF PRINT
Extra-mitral valve cardiac involvement in MR
FREE ARTICLE - Antonio Popolo Rubbio et al
November 9, 2023